Oritavancin for Treatment of Serious Cardiac Infections
Oritavancin for Treatment of Serious Cardiac Infections
Not yet recruiting · NCT07550595 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oritavancin for Treatment of Serious Cardiac Infections | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, cardiovascular disorder, endocarditis, gram-positive bacterial infections, heart disorder, infective endocarditis | Not yet recruiting | Phase 2 | 2026-04-29 | NCT07550595 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kirby Institute | 19 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Prince of Wales Hospital | Sydney | Australia | 12 |
| Royal Prince Alfred Hospital | Sydney | Australia | 19 |
| St Vincent's Hospital | Sydney | Australia | 12 |